Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene therapy
gene therapy
Hear hear! Ear gene therapy player Akouos draws $105M in fresh capital
Endpoints
Tue, 03/3/20 - 11:58 pm
Akouos
hearing loss
gene therapy
Jim Wilson's gene therapy startup Passage Bio bucks market sentiments, raising upsized $216M IPO
Endpoints
Fri, 02/28/20 - 10:37 am
Passage Bio
IPOs
gene therapy
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
BioMarin's Novel Treatment Promises to Disrupt Competitors
Motley Fool
Wed, 02/26/20 - 10:45 am
Biomarin
gene therapy
valrox
hemophilia A
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Motley Fool
Fri, 02/21/20 - 11:39 pm
Repligen
earnings
gene therapy
FDA Gives BioMarin Pharmaceuticals' Hemophilia Gene Therapy Priority Review
Motley Fool
Thu, 02/20/20 - 11:41 pm
FDA
Biomarin
priority review
valrox
gene therapy
hemophilia A
FDA Awards Orphan Drug Designation to Prevail's Gene Therapy for Gaucher Disease
BioSpace
Fri, 02/14/20 - 10:47 am
FDA
Prevail Therapeutics
gene therapy
Gaucher disease
Upcoming events – Avadel takes on Jazz and Axovant awaits early results
EP Vantage
Fri, 02/14/20 - 10:35 am
Avadel
FT218
Jazz Pharmaceuticals
Xyrem
Axovant
gene therapy
Parkinson's Disease
narcolepsy
Novartis faces criticism over Zolgensma ‘health lottery’
PM Live
Thu, 02/6/20 - 11:51 pm
Novartis
SMA
gene therapy
Zolgensma
lottery
Drugmaker BioMarin Seeks New CFO Amid Coming Release Of Potentially Costliest Drug In The World
Forbes
Thu, 02/6/20 - 11:37 pm
Biomarin
valrox
gene therapy
hemophilia A
Catalent laying out $315M to snatch another gene therapy CDMO
Fierce Pharma
Mon, 02/3/20 - 10:39 am
Catalent
gene therapy
Paragon Services
CDMOs
FDA Expects Explosion in Gene Therapy Treatments, Updates Review Policy
Motley Fool
Tue, 01/28/20 - 11:43 pm
FDA
gene therapy
Deerfield vaults to the top of cell and gene therapy CDMO game with $1.1B facility at Philadelphia's newest biopharma hub
Endpoints
Sat, 01/25/20 - 11:27 pm
Deerfield Management
gene therapy
IPOs
CDMOs
Philadelphia
BioMarin sets gene therapy sights beyond hemophilia
BioPharma Dive
Mon, 01/13/20 - 11:40 pm
Biomarin
hemophilia
gene therapy
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans
Xconomy
Mon, 01/13/20 - 11:38 pm
gene therapy
IPOs
Generation Bio
Ultragenyx shares jump on 'better than expected' gene therapy data
Fierce Biotech
Fri, 01/10/20 - 10:26 am
Ultragenyx
clinical trials
gene therapy
DTX301
Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track
Xconomy
Thu, 01/9/20 - 10:35 am
Solid Biosciences
gene therapy
reorganization
Duchenne Muscular Dystrophy
3 trends in biotech to watch in 2020
Stat
Mon, 12/30/19 - 10:34 am
IPOs
eteplirsen
CAR-T
gene therapy
cell therapy
biotech
Pharma's gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles
Fierce Pharma
Thu, 12/19/19 - 01:11 pm
gene therapy
reimbursement
drug manufacturing
Bristol-Myers Squibb
Pfizer
Biomarin
Sarepta Therapeutics
Gilead Sciences
CAR-T
Zolgensma for free? Yes, but advocates worry about Novartis' lottery-style giveaway
Fierce Pharma
Thu, 12/19/19 - 12:57 pm
Novartis
Zolgensma
SMA
gene therapy
drug pricing
patients
Pages
« first
‹ previous
…
20
21
22
23
24
25
26
27
28
…
next ›
last »